Discussion  by unknown
thromboembolism, hemolysis, andmechanical failure, could
be minimized if the maturation period were shortened. We
have reported that both unfractionated and low molecular
weight heparin accelerate pulmonary vascular maturation
in neonatal rabbits by 250% and that this was characterized
by significantly lower PA pressure at 2 weeks of age.19 Fur-
ther development of this ‘‘chemo-mechanical lung assist’’
strategy might facilitate a paradigm shift in the surgical treat-
ment of hypoplastic left heart syndrome. Many issues re-
main to be explored before this strategy can be applied
clinically.
Study Limitations
There are certain limitations in this study. First, this is not
a true cyanotic single ventricle model, but rather a high PVR
cavopulmonary shunt model. Therefore, this study provided
little data regarding the effects of MCPA on systemic hemo-
dynamic, metabolism, and oxygenation and ventilation in
a functional single ventricle physiology. Second, the short
duration of the study provided little data regarding the pos-
sibility of long-term cavopulmonary assist using this type
of system. A long-term study will be required to focus on,
among other factors, anticoagulation, thrombosis, and
pump sustainability. Third, the banded SVC, which was suc-
cessfully dilated with a balloon catheter, may not be so sim-
ply dilated after long-term mechanical assist. Finally, the
band placed on the SVC prevented circular flow from the
PA to the SVC in the MCPA group. It also prevented retro-
grade flow in the SVC from right ventricular ejection. Be-
cause this is a 1½-ventricle model, the control animals
would have had retrograde flow in the SVC during right ven-
tricular ejection. As such, the control animals’ cerebral phys-
iology would be different from a single ventricle model of
a high PVR cavopulmonary connection.
CONCLUSIONS
MCPA maintained BCPS flow, thereby sustaining the
1½-ventricle repair physiology with reasonable systemic
hemodynamics and metabolism in neonatal pigs. This ap-
proach also maintained cerebral blood flow and metabolism
by efficiently decompressing SVC pressure and maintaining
an adequate transcerebral pressure gradient. This study con-
ceptually raises the possibility of a primary BCPS creation in
neonates with the aid of MCPA followed by catheter-based
explantation of the pump system.
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DDiscussion
Dr William Gaynor (Philadelphia, Pa). Why did you use the
1½-ventricle model? Why not ligate the main PA? In your no—as-
sist group the PA is not banded, thus the right ventricle is able to
eject and you are going to have a high SVC pressure. Basically,
by banding the assist group you are just looking at a pump decom-
pression of the SVC. It does not seem like a fair comparison of the
two groups.Why not clamp the main PA and look at a pure superior
cavopulmonary connection model rather than a 1½-ventricle
model?
Dr Honjo. Thank you for your question. There are a couple
of reasons why we used this model. The advantage of thisrgery c February 2009
Honjo et al Congenital Heart Disease
Dmodel is that we can actually separate the cerebral circulation
from the systemic circulation, looking at the effect of the
pump system on the cerebral circulation and the metabolism.
However, the disadvantage, as you mentioned, is that this is
not a single ventricle model, meaning this is not a cyanotic
model. We cannot compare the systemic oxygenation or ventila-
tion. We have actually done the single ventricle model in which
we created the single left ventricle under CPB with a cavopulmo-
nary shunt as the primary blood source. That essentially showed
that mechanical support extended the survival and also improved
carbon dioxide exchange and oxygenation. However, because
we had to use CPB, which deteriorates the systemic metabolism,
that is not a good model to compare the cerebral perfusion in
a fine way. That is why in this particular study we used this
model.The Journal of Thoracic and CDr Y. Joseph Woo (Philadelphia, Pa). With the way you dis-
played your model, depending on the flow rate that you establish
within your pump, you could establish some degree of a closed
loop circulation. How did you titrate how tightly to band the
SVC to prevent such a closed loop circulation?
Dr Honjo. That is a very good question. This SVC band is very
tight, because we do not want retrograde flow getting into the pump
system, which makes a noneffective circulation. We do not want to
occlude the SVC because we would eventually use it for a cavopul-
monary shunt. However, this SVC band that we use is very tight.
This is one of the disadvantages of using this pump system. Actu-
ally, if you use a different pump system, like a small axial pump,
you can insert it into the SVC, and we do not need such a band.
It might be beneficial, but we do not have a pump small enough
to be inserted into the SVC.ardiovascular Surgery c Volume 137, Number 2 361
C
H
